Editorial

The metabolic syndrome: A tug-of-war with no winner

Author and Disclosure Information

ABSTRACTThe metabolic syndrome may be viewed as a state of insulin-counterregulatory overdrive: counterregulatory hormones and fatty acids chronically duel with insulin, causing a cascade of biochemical interactions resulting in insulin resistance, hypertension, and dyslipidemia. Even before beta cells fail and type 2 diabetes ensues, the deadly quartet is quietly rehearsing.


 

Recommended Reading

In patients with diabetes and hypertension, should treatment start with an ACE inhibitor instead of a diuretic or beta blocker?
Type 2 Diabetes ICYMI
What is the relative cardiovascular benefit of lowering cholesterol, blood pressure, and glucose levels in patients with type 2 diabetes?
Type 2 Diabetes ICYMI
What is the protective effect of previous coronary artery bypass graft compared with percutaneous transluminal coronary angioplasty in patients with diabetes who suffer an acute myocardial infarction?
Type 2 Diabetes ICYMI
In diabetes, treat hidden heart disease
Type 2 Diabetes ICYMI
Ramipril lowered cardiovascular risk, but vitamin E did not
Type 2 Diabetes ICYMI
The HOPE study
Type 2 Diabetes ICYMI
Long-term medical complications of heart transplantation: Information for the primary care physician
Type 2 Diabetes ICYMI
Aggressive treatment of dyslipidemia: A review of supporting evidence
Type 2 Diabetes ICYMI
Should an ACE inhibitor be stopped if signs of renal insufficiency appear?
Type 2 Diabetes ICYMI

Related Articles